nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—Drug hypersensitivity—Epirubicin—bone cancer	0.0196	0.0204	CcSEcCtD
Lacosamide—Cognitive disorder—Methotrexate—bone cancer	0.0195	0.0203	CcSEcCtD
Lacosamide—Drug hypersensitivity—Doxorubicin—bone cancer	0.0181	0.0189	CcSEcCtD
Lacosamide—Dysarthria—Cisplatin—bone cancer	0.0163	0.0169	CcSEcCtD
Lacosamide—Felbamate—CYP3A4—bone cancer	0.0154	0.401	CrCbGaD
Lacosamide—Body temperature increased—Carboplatin—bone cancer	0.0148	0.0154	CcSEcCtD
Lacosamide—Bortezomib—CYP3A4—bone cancer	0.0114	0.297	CrCbGaD
Lacosamide—Nystagmus—Epirubicin—bone cancer	0.0111	0.0115	CcSEcCtD
Lacosamide—Irritability—Cisplatin—bone cancer	0.0107	0.0111	CcSEcCtD
Lacosamide—Nystagmus—Doxorubicin—bone cancer	0.0102	0.0106	CcSEcCtD
Lacosamide—Injection site pain—Epirubicin—bone cancer	0.00967	0.0101	CcSEcCtD
Lacosamide—Proteinuria—Methotrexate—bone cancer	0.00961	0.00999	CcSEcCtD
Lacosamide—Protein urine present—Methotrexate—bone cancer	0.00947	0.00985	CcSEcCtD
Lacosamide—Blood disorder—Epirubicin—bone cancer	0.00946	0.00983	CcSEcCtD
Lacosamide—Injection site pain—Doxorubicin—bone cancer	0.00895	0.00931	CcSEcCtD
Lacosamide—Dysarthria—Methotrexate—bone cancer	0.00892	0.00928	CcSEcCtD
Lacosamide—Blood disorder—Doxorubicin—bone cancer	0.00875	0.0091	CcSEcCtD
Lacosamide—Dysarthria—Epirubicin—bone cancer	0.00835	0.00868	CcSEcCtD
Lacosamide—Atrioventricular block—Epirubicin—bone cancer	0.00814	0.00847	CcSEcCtD
Lacosamide—Hepatobiliary disease—Cisplatin—bone cancer	0.00814	0.00846	CcSEcCtD
Lacosamide—Gait disturbance—Epirubicin—bone cancer	0.00809	0.00842	CcSEcCtD
Lacosamide—Coordination abnormal—Epirubicin—bone cancer	0.00804	0.00836	CcSEcCtD
Lacosamide—Bradycardia—Cisplatin—bone cancer	0.00786	0.00818	CcSEcCtD
Lacosamide—Dysarthria—Doxorubicin—bone cancer	0.00773	0.00803	CcSEcCtD
Lacosamide—Connective tissue disorder—Cisplatin—bone cancer	0.00759	0.00789	CcSEcCtD
Lacosamide—Atrioventricular block—Doxorubicin—bone cancer	0.00753	0.00783	CcSEcCtD
Lacosamide—Gait disturbance—Doxorubicin—bone cancer	0.00749	0.00779	CcSEcCtD
Lacosamide—Coordination abnormal—Doxorubicin—bone cancer	0.00744	0.00774	CcSEcCtD
Lacosamide—Eye disorder—Cisplatin—bone cancer	0.00722	0.00751	CcSEcCtD
Lacosamide—Tinnitus—Cisplatin—bone cancer	0.0072	0.00749	CcSEcCtD
Lacosamide—Cardiac disorder—Cisplatin—bone cancer	0.00717	0.00745	CcSEcCtD
Lacosamide—Immune system disorder—Cisplatin—bone cancer	0.00698	0.00725	CcSEcCtD
Lacosamide—Erythema—Cisplatin—bone cancer	0.00672	0.00699	CcSEcCtD
Lacosamide—Flatulence—Cisplatin—bone cancer	0.00663	0.00689	CcSEcCtD
Lacosamide—Muscle spasms—Cisplatin—bone cancer	0.00646	0.00672	CcSEcCtD
Lacosamide—Vision blurred—Cisplatin—bone cancer	0.00634	0.00659	CcSEcCtD
Lacosamide—Tremor—Cisplatin—bone cancer	0.0063	0.00655	CcSEcCtD
Lacosamide—Anaemia—Cisplatin—bone cancer	0.00621	0.00646	CcSEcCtD
Lacosamide—Osteoarthritis—Methotrexate—bone cancer	0.00613	0.00637	CcSEcCtD
Lacosamide—Irritability—Methotrexate—bone cancer	0.00585	0.00608	CcSEcCtD
Lacosamide—Nateglinide—CYP3A4—bone cancer	0.00584	0.152	CrCbGaD
Lacosamide—Mood swings—Methotrexate—bone cancer	0.0058	0.00604	CcSEcCtD
Lacosamide—Ataxia—Methotrexate—bone cancer	0.00576	0.00599	CcSEcCtD
Lacosamide—Phenelzine—CYP3A4—bone cancer	0.00576	0.15	CrCbGaD
Lacosamide—Osteoarthritis—Epirubicin—bone cancer	0.00573	0.00596	CcSEcCtD
Lacosamide—Diplopia—Epirubicin—bone cancer	0.00573	0.00596	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00568	0.00591	CcSEcCtD
Lacosamide—Liver function test abnormal—Methotrexate—bone cancer	0.00566	0.00588	CcSEcCtD
Lacosamide—Discomfort—Cisplatin—bone cancer	0.00566	0.00588	CcSEcCtD
Lacosamide—Affect lability—Epirubicin—bone cancer	0.00564	0.00587	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00552	0.00574	CcSEcCtD
Lacosamide—Mood swings—Epirubicin—bone cancer	0.00543	0.00565	CcSEcCtD
Lacosamide—Ataxia—Epirubicin—bone cancer	0.00539	0.00561	CcSEcCtD
Lacosamide—Nervous system disorder—Cisplatin—bone cancer	0.00538	0.0056	CcSEcCtD
Lacosamide—Skin disorder—Cisplatin—bone cancer	0.00533	0.00554	CcSEcCtD
Lacosamide—Diplopia—Doxorubicin—bone cancer	0.0053	0.00552	CcSEcCtD
Lacosamide—Osteoarthritis—Doxorubicin—bone cancer	0.0053	0.00552	CcSEcCtD
Lacosamide—Hyperhidrosis—Cisplatin—bone cancer	0.0053	0.00552	CcSEcCtD
Lacosamide—Liver function test abnormal—Epirubicin—bone cancer	0.00529	0.0055	CcSEcCtD
Lacosamide—Eosinophilia—Methotrexate—bone cancer	0.00524	0.00545	CcSEcCtD
Lacosamide—Affect lability—Doxorubicin—bone cancer	0.00522	0.00543	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00516	0.00537	CcSEcCtD
Lacosamide—Mood swings—Doxorubicin—bone cancer	0.00503	0.00523	CcSEcCtD
Lacosamide—Ataxia—Doxorubicin—bone cancer	0.00499	0.00519	CcSEcCtD
Lacosamide—Neutropenia—Methotrexate—bone cancer	0.00495	0.00515	CcSEcCtD
Lacosamide—Paraesthesia—Cisplatin—bone cancer	0.00493	0.00512	CcSEcCtD
Lacosamide—Eosinophilia—Epirubicin—bone cancer	0.00491	0.0051	CcSEcCtD
Lacosamide—Liver function test abnormal—Doxorubicin—bone cancer	0.0049	0.00509	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00478	0.00497	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Cisplatin—bone cancer	0.00474	0.00493	CcSEcCtD
Lacosamide—Depression—Methotrexate—bone cancer	0.00471	0.0049	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.00468	0.00487	CcSEcCtD
Lacosamide—Neutropenia—Epirubicin—bone cancer	0.00463	0.00482	CcSEcCtD
Lacosamide—Eosinophilia—Doxorubicin—bone cancer	0.00454	0.00472	CcSEcCtD
Lacosamide—Feeling abnormal—Cisplatin—bone cancer	0.00452	0.0047	CcSEcCtD
Lacosamide—Hepatobiliary disease—Methotrexate—bone cancer	0.00446	0.00464	CcSEcCtD
Lacosamide—Agranulocytosis—Methotrexate—bone cancer	0.00441	0.00458	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00438	0.00455	CcSEcCtD
Lacosamide—Body temperature increased—Cisplatin—bone cancer	0.00434	0.00451	CcSEcCtD
Lacosamide—Neutropenia—Doxorubicin—bone cancer	0.00429	0.00446	CcSEcCtD
Lacosamide—Hepatitis—Methotrexate—bone cancer	0.00424	0.00441	CcSEcCtD
Lacosamide—Hepatobiliary disease—Epirubicin—bone cancer	0.00418	0.00435	CcSEcCtD
Lacosamide—Agranulocytosis—Epirubicin—bone cancer	0.00412	0.00429	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00405	0.00421	CcSEcCtD
Lacosamide—Hypersensitivity—Cisplatin—bone cancer	0.00404	0.0042	CcSEcCtD
Lacosamide—Bradycardia—Epirubicin—bone cancer	0.00404	0.0042	CcSEcCtD
Lacosamide—Erythema multiforme—Methotrexate—bone cancer	0.00401	0.00417	CcSEcCtD
Lacosamide—Hepatitis—Epirubicin—bone cancer	0.00397	0.00412	CcSEcCtD
Lacosamide—Eye disorder—Methotrexate—bone cancer	0.00396	0.00412	CcSEcCtD
Lacosamide—Tinnitus—Methotrexate—bone cancer	0.00395	0.00411	CcSEcCtD
Lacosamide—Hypoaesthesia—Epirubicin—bone cancer	0.00395	0.0041	CcSEcCtD
Lacosamide—Asthenia—Cisplatin—bone cancer	0.00394	0.00409	CcSEcCtD
Lacosamide—Cardiac disorder—Methotrexate—bone cancer	0.00393	0.00409	CcSEcCtD
Lacosamide—Connective tissue disorder—Epirubicin—bone cancer	0.0039	0.00405	CcSEcCtD
Lacosamide—Hepatobiliary disease—Doxorubicin—bone cancer	0.00387	0.00402	CcSEcCtD
Lacosamide—Immune system disorder—Methotrexate—bone cancer	0.00383	0.00398	CcSEcCtD
Lacosamide—Agranulocytosis—Doxorubicin—bone cancer	0.00381	0.00397	CcSEcCtD
Lacosamide—Diarrhoea—Cisplatin—bone cancer	0.00375	0.0039	CcSEcCtD
Lacosamide—Erythema multiforme—Epirubicin—bone cancer	0.00375	0.0039	CcSEcCtD
Lacosamide—Bradycardia—Doxorubicin—bone cancer	0.00374	0.00389	CcSEcCtD
Lacosamide—Mental disorder—Methotrexate—bone cancer	0.00371	0.00386	CcSEcCtD
Lacosamide—Eye disorder—Epirubicin—bone cancer	0.00371	0.00385	CcSEcCtD
Lacosamide—Tinnitus—Epirubicin—bone cancer	0.0037	0.00385	CcSEcCtD
Lacosamide—Erythema—Methotrexate—bone cancer	0.00369	0.00384	CcSEcCtD
Lacosamide—Cardiac disorder—Epirubicin—bone cancer	0.00368	0.00383	CcSEcCtD
Lacosamide—Hepatitis—Doxorubicin—bone cancer	0.00367	0.00382	CcSEcCtD
Lacosamide—Hypoaesthesia—Doxorubicin—bone cancer	0.00365	0.0038	CcSEcCtD
Lacosamide—Connective tissue disorder—Doxorubicin—bone cancer	0.00361	0.00375	CcSEcCtD
Lacosamide—Immune system disorder—Epirubicin—bone cancer	0.00358	0.00373	CcSEcCtD
Lacosamide—Vomiting—Cisplatin—bone cancer	0.00349	0.00363	CcSEcCtD
Lacosamide—Vision blurred—Methotrexate—bone cancer	0.00348	0.00362	CcSEcCtD
Lacosamide—Mental disorder—Epirubicin—bone cancer	0.00347	0.00361	CcSEcCtD
Lacosamide—Erythema multiforme—Doxorubicin—bone cancer	0.00347	0.00361	CcSEcCtD
Lacosamide—Rash—Cisplatin—bone cancer	0.00346	0.0036	CcSEcCtD
Lacosamide—Dermatitis—Cisplatin—bone cancer	0.00346	0.00359	CcSEcCtD
Lacosamide—Erythema—Epirubicin—bone cancer	0.00345	0.00359	CcSEcCtD
Lacosamide—Eye disorder—Doxorubicin—bone cancer	0.00343	0.00357	CcSEcCtD
Lacosamide—Tinnitus—Doxorubicin—bone cancer	0.00342	0.00356	CcSEcCtD
Lacosamide—Anaemia—Methotrexate—bone cancer	0.00341	0.00355	CcSEcCtD
Lacosamide—Cardiac disorder—Doxorubicin—bone cancer	0.00341	0.00354	CcSEcCtD
Lacosamide—Flatulence—Epirubicin—bone cancer	0.0034	0.00354	CcSEcCtD
Lacosamide—Muscle spasms—Epirubicin—bone cancer	0.00332	0.00345	CcSEcCtD
Lacosamide—Immune system disorder—Doxorubicin—bone cancer	0.00331	0.00345	CcSEcCtD
Lacosamide—Vertigo—Methotrexate—bone cancer	0.00331	0.00345	CcSEcCtD
Lacosamide—Nausea—Cisplatin—bone cancer	0.00326	0.00339	CcSEcCtD
Lacosamide—Vision blurred—Epirubicin—bone cancer	0.00325	0.00338	CcSEcCtD
Lacosamide—Mental disorder—Doxorubicin—bone cancer	0.00322	0.00334	CcSEcCtD
Lacosamide—Erythema—Doxorubicin—bone cancer	0.00319	0.00332	CcSEcCtD
Lacosamide—Anaemia—Epirubicin—bone cancer	0.00319	0.00332	CcSEcCtD
Lacosamide—Agitation—Epirubicin—bone cancer	0.00317	0.0033	CcSEcCtD
Lacosamide—Flatulence—Doxorubicin—bone cancer	0.00315	0.00327	CcSEcCtD
Lacosamide—Chest pain—Methotrexate—bone cancer	0.00314	0.00327	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00312	0.00324	CcSEcCtD
Lacosamide—Discomfort—Methotrexate—bone cancer	0.0031	0.00323	CcSEcCtD
Lacosamide—Vertigo—Epirubicin—bone cancer	0.0031	0.00323	CcSEcCtD
Lacosamide—Syncope—Epirubicin—bone cancer	0.0031	0.00322	CcSEcCtD
Lacosamide—Muscle spasms—Doxorubicin—bone cancer	0.00307	0.00319	CcSEcCtD
Lacosamide—Palpitations—Epirubicin—bone cancer	0.00305	0.00317	CcSEcCtD
Lacosamide—Confusional state—Methotrexate—bone cancer	0.00304	0.00316	CcSEcCtD
Lacosamide—Loss of consciousness—Epirubicin—bone cancer	0.00303	0.00316	CcSEcCtD
Lacosamide—Vision blurred—Doxorubicin—bone cancer	0.00301	0.00313	CcSEcCtD
Lacosamide—Nervous system disorder—Methotrexate—bone cancer	0.00295	0.00307	CcSEcCtD
Lacosamide—Anaemia—Doxorubicin—bone cancer	0.00295	0.00307	CcSEcCtD
Lacosamide—Chest pain—Epirubicin—bone cancer	0.00294	0.00306	CcSEcCtD
Lacosamide—Agitation—Doxorubicin—bone cancer	0.00294	0.00305	CcSEcCtD
Lacosamide—Skin disorder—Methotrexate—bone cancer	0.00292	0.00304	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00292	0.00304	CcSEcCtD
Lacosamide—Hyperhidrosis—Methotrexate—bone cancer	0.00291	0.00303	CcSEcCtD
Lacosamide—Discomfort—Epirubicin—bone cancer	0.0029	0.00302	CcSEcCtD
Lacosamide—Dry mouth—Epirubicin—bone cancer	0.00287	0.00299	CcSEcCtD
Lacosamide—Vertigo—Doxorubicin—bone cancer	0.00287	0.00298	CcSEcCtD
Lacosamide—Syncope—Doxorubicin—bone cancer	0.00286	0.00298	CcSEcCtD
Lacosamide—Confusional state—Epirubicin—bone cancer	0.00284	0.00295	CcSEcCtD
Lacosamide—Palpitations—Doxorubicin—bone cancer	0.00282	0.00294	CcSEcCtD
Lacosamide—Loss of consciousness—Doxorubicin—bone cancer	0.00281	0.00292	CcSEcCtD
Lacosamide—Shock—Epirubicin—bone cancer	0.00277	0.00288	CcSEcCtD
Lacosamide—Nervous system disorder—Epirubicin—bone cancer	0.00276	0.00287	CcSEcCtD
Lacosamide—Skin disorder—Epirubicin—bone cancer	0.00274	0.00285	CcSEcCtD
Lacosamide—Hyperhidrosis—Epirubicin—bone cancer	0.00272	0.00283	CcSEcCtD
Lacosamide—Insomnia—Methotrexate—bone cancer	0.00272	0.00283	CcSEcCtD
Lacosamide—Chest pain—Doxorubicin—bone cancer	0.00272	0.00283	CcSEcCtD
Lacosamide—Paraesthesia—Methotrexate—bone cancer	0.0027	0.00281	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.0027	0.00281	CcSEcCtD
Lacosamide—Discomfort—Doxorubicin—bone cancer	0.00269	0.00279	CcSEcCtD
Lacosamide—Somnolence—Methotrexate—bone cancer	0.00268	0.00278	CcSEcCtD
Lacosamide—Dry mouth—Doxorubicin—bone cancer	0.00266	0.00277	CcSEcCtD
Lacosamide—Dyspepsia—Methotrexate—bone cancer	0.00265	0.00276	CcSEcCtD
Lacosamide—Confusional state—Doxorubicin—bone cancer	0.00263	0.00273	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Methotrexate—bone cancer	0.0026	0.0027	CcSEcCtD
Lacosamide—Fatigue—Methotrexate—bone cancer	0.0026	0.0027	CcSEcCtD
Lacosamide—Shock—Doxorubicin—bone cancer	0.00257	0.00267	CcSEcCtD
Lacosamide—Nervous system disorder—Doxorubicin—bone cancer	0.00256	0.00266	CcSEcCtD
Lacosamide—Insomnia—Epirubicin—bone cancer	0.00255	0.00265	CcSEcCtD
Lacosamide—Skin disorder—Doxorubicin—bone cancer	0.00253	0.00263	CcSEcCtD
Lacosamide—Paraesthesia—Epirubicin—bone cancer	0.00253	0.00263	CcSEcCtD
Lacosamide—Hyperhidrosis—Doxorubicin—bone cancer	0.00252	0.00262	CcSEcCtD
Lacosamide—Somnolence—Epirubicin—bone cancer	0.00251	0.0026	CcSEcCtD
Lacosamide—Feeling abnormal—Methotrexate—bone cancer	0.00248	0.00258	CcSEcCtD
Lacosamide—Dyspepsia—Epirubicin—bone cancer	0.00248	0.00258	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Epirubicin—bone cancer	0.00243	0.00253	CcSEcCtD
Lacosamide—Fatigue—Epirubicin—bone cancer	0.00243	0.00253	CcSEcCtD
Lacosamide—Constipation—Epirubicin—bone cancer	0.00241	0.00251	CcSEcCtD
Lacosamide—Urticaria—Methotrexate—bone cancer	0.00239	0.00249	CcSEcCtD
Lacosamide—Body temperature increased—Methotrexate—bone cancer	0.00238	0.00248	CcSEcCtD
Lacosamide—Insomnia—Doxorubicin—bone cancer	0.00236	0.00245	CcSEcCtD
Lacosamide—Paraesthesia—Doxorubicin—bone cancer	0.00234	0.00243	CcSEcCtD
Lacosamide—Feeling abnormal—Epirubicin—bone cancer	0.00232	0.00241	CcSEcCtD
Lacosamide—Somnolence—Doxorubicin—bone cancer	0.00232	0.00241	CcSEcCtD
Lacosamide—Dyspepsia—Doxorubicin—bone cancer	0.0023	0.00239	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00225	0.00234	CcSEcCtD
Lacosamide—Fatigue—Doxorubicin—bone cancer	0.00225	0.00234	CcSEcCtD
Lacosamide—Urticaria—Epirubicin—bone cancer	0.00224	0.00233	CcSEcCtD
Lacosamide—Constipation—Doxorubicin—bone cancer	0.00223	0.00232	CcSEcCtD
Lacosamide—Body temperature increased—Epirubicin—bone cancer	0.00223	0.00232	CcSEcCtD
Lacosamide—Hypersensitivity—Methotrexate—bone cancer	0.00222	0.00231	CcSEcCtD
Lacosamide—Asthenia—Methotrexate—bone cancer	0.00216	0.00225	CcSEcCtD
Lacosamide—Feeling abnormal—Doxorubicin—bone cancer	0.00215	0.00223	CcSEcCtD
Lacosamide—Pruritus—Methotrexate—bone cancer	0.00213	0.00222	CcSEcCtD
Lacosamide—Hypersensitivity—Epirubicin—bone cancer	0.00208	0.00216	CcSEcCtD
Lacosamide—Urticaria—Doxorubicin—bone cancer	0.00207	0.00215	CcSEcCtD
Lacosamide—Body temperature increased—Doxorubicin—bone cancer	0.00206	0.00214	CcSEcCtD
Lacosamide—Diarrhoea—Methotrexate—bone cancer	0.00206	0.00214	CcSEcCtD
Lacosamide—Asthenia—Epirubicin—bone cancer	0.00202	0.0021	CcSEcCtD
Lacosamide—Pruritus—Epirubicin—bone cancer	0.00199	0.00207	CcSEcCtD
Lacosamide—Dizziness—Methotrexate—bone cancer	0.00199	0.00207	CcSEcCtD
Lacosamide—Diarrhoea—Epirubicin—bone cancer	0.00193	0.002	CcSEcCtD
Lacosamide—Hypersensitivity—Doxorubicin—bone cancer	0.00192	0.002	CcSEcCtD
Lacosamide—Vomiting—Methotrexate—bone cancer	0.00191	0.00199	CcSEcCtD
Lacosamide—Rash—Methotrexate—bone cancer	0.0019	0.00197	CcSEcCtD
Lacosamide—Dermatitis—Methotrexate—bone cancer	0.0019	0.00197	CcSEcCtD
Lacosamide—Headache—Methotrexate—bone cancer	0.00189	0.00196	CcSEcCtD
Lacosamide—Asthenia—Doxorubicin—bone cancer	0.00187	0.00195	CcSEcCtD
Lacosamide—Dizziness—Epirubicin—bone cancer	0.00186	0.00194	CcSEcCtD
Lacosamide—Pruritus—Doxorubicin—bone cancer	0.00184	0.00192	CcSEcCtD
Lacosamide—Vomiting—Epirubicin—bone cancer	0.00179	0.00186	CcSEcCtD
Lacosamide—Nausea—Methotrexate—bone cancer	0.00179	0.00186	CcSEcCtD
Lacosamide—Diarrhoea—Doxorubicin—bone cancer	0.00178	0.00186	CcSEcCtD
Lacosamide—Rash—Epirubicin—bone cancer	0.00178	0.00185	CcSEcCtD
Lacosamide—Dermatitis—Epirubicin—bone cancer	0.00178	0.00185	CcSEcCtD
Lacosamide—Headache—Epirubicin—bone cancer	0.00177	0.00184	CcSEcCtD
Lacosamide—Dizziness—Doxorubicin—bone cancer	0.00172	0.00179	CcSEcCtD
Lacosamide—Nausea—Epirubicin—bone cancer	0.00167	0.00174	CcSEcCtD
Lacosamide—Vomiting—Doxorubicin—bone cancer	0.00166	0.00172	CcSEcCtD
Lacosamide—Rash—Doxorubicin—bone cancer	0.00164	0.00171	CcSEcCtD
Lacosamide—Dermatitis—Doxorubicin—bone cancer	0.00164	0.00171	CcSEcCtD
Lacosamide—Headache—Doxorubicin—bone cancer	0.00163	0.0017	CcSEcCtD
Lacosamide—Nausea—Doxorubicin—bone cancer	0.00155	0.00161	CcSEcCtD
